Market shares for key players supplying GERD devices in the U.S. are shown in the chart at right.
Gastroesophageal reflux disease (GERD) is a growing problem affecting approximately 5% of the population. An estimated $10 billion is spent on GERD in the United States each year. It is primarily treated with medical therapies (e.g., proton pump [...]
bookmark to
